These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 33924829)

  • 1. Establishment of Colorectal Cancer Organoids in Microfluidic-Based System.
    Pinho D; Santos D; Vila A; Carvalho S
    Micromachines (Basel); 2021 Apr; 12(5):. PubMed ID: 33924829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OrganoidChip facilitates hydrogel-free immobilization for fast and blur-free imaging of organoids.
    Moshksayan K; Harihara A; Mondal S; Hegarty E; Atherly T; Sahoo DK; Jergens AE; Mochel JP; Allenspach K; Zoldan J; Ben-Yakar A
    Sci Rep; 2023 Jul; 13(1):11268. PubMed ID: 37438409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing prodrug metabolism and reciprocal toxicity with an integrated and humanized multi-tissue organ-on-a-chip platform.
    Rajan SAP; Aleman J; Wan M; Pourhabibi Zarandi N; Nzou G; Murphy S; Bishop CE; Sadri-Ardekani H; Shupe T; Atala A; Hall AR; Skardal A
    Acta Biomater; 2020 Apr; 106():124-135. PubMed ID: 32068138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dual-functional microfluidic chip for guiding personalized lung cancer medicine: combining EGFR mutation detection and organoid-based drug response test.
    Zhang K; Xi J; Zhao H; Wang Y; Xue J; Liang N; Wei Z
    Lab Chip; 2024 Mar; 24(6):1762-1774. PubMed ID: 38352981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
    Xie BY; Wu AW
    Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank.
    Zhou Z; Cong L; Cong X
    Front Oncol; 2021; 11():762184. PubMed ID: 35036354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy.
    Qu J; Kalyani FS; Liu L; Cheng T; Chen L
    Cancer Commun (Lond); 2021 Dec; 41(12):1331-1353. PubMed ID: 34713636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organoid technology for personalized pancreatic cancer therapy.
    Bengtsson A; Andersson R; Rahm J; Ganganna K; Andersson B; Ansari D
    Cell Oncol (Dordr); 2021 Apr; 44(2):251-260. PubMed ID: 33492660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microfluidic Organoids-on-a-Chip: Quantum Leap in Cancer Research.
    Duzagac F; Saorin G; Memeo L; Canzonieri V; Rizzolio F
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33578886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-derived cancer organoids for drug screening: Basic technology and clinical application.
    Ren X; Chen W; Yang Q; Li X; Xu L
    J Gastroenterol Hepatol; 2022 Aug; 37(8):1446-1454. PubMed ID: 35771719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application Progress of Organoids in Colorectal Cancer.
    Luo L; Ma Y; Zheng Y; Su J; Huang G
    Front Cell Dev Biol; 2022; 10():815067. PubMed ID: 35273961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-derived organoids as a preclinical platform for precision medicine in colorectal cancer.
    Cho YW; Min DW; Kim HP; An Y; Kim S; Youk J; Chun J; Im JP; Song SH; Ju YS; Han SW; Park KJ; Kim TY
    Mol Oncol; 2022 Jun; 16(12):2396-2412. PubMed ID: 34850547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-Derived Organoids of Colorectal Cancer: A Useful Tool for Personalized Medicine.
    Kiwaki T; Kataoka H
    J Pers Med; 2022 Apr; 12(5):. PubMed ID: 35629118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold.
    Hu LF; Yang X; Lan HR; Fang XL; Chen XY; Jin KT
    Exp Cell Res; 2021 Nov; 408(2):112858. PubMed ID: 34600901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal organs and organoids-on-a-chip: advances and translation into the clinics.
    Carvalho MR; Yan LP; Li B; Zhang CH; He YL; Reis RL; Oliveira JM
    Biofabrication; 2023 Sep; 15(4):. PubMed ID: 37699408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in three-dimensional tumor models for colorectal cancer].
    Wang CT; Zhou JL; Lin GL; Yin SY; Cong L; Zhang GN; An Y; Qiu XY
    Zhonghua Zhong Liu Za Zhi; 2023 Jun; 45(6):464-470. PubMed ID: 37355464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recapitulation of First Pass Metabolism Using 3D Printed Microfluidic Chip and Organoid.
    Lee BE; Kim DK; Lee H; Yoon S; Park SH; Lee S; Yoo J
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response.
    Smabers LP; Wensink E; Verissimo CS; Koedoot E; Pitsa KC; Huismans MA; Higuera Barón C; Doorn M; Valkenburg-van Iersel LB; Cirkel GA; Brousali A; Overmeer R; Koopman M; Braat MN; Penning de Vries B; Elias SG; Vries RG; Kranenburg O; Boj SF; Roodhart JM
    J Exp Clin Cancer Res; 2024 Feb; 43(1):61. PubMed ID: 38414064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organoid and Spheroid Tumor Models: Techniques and Applications.
    Gunti S; Hoke ATK; Vu KP; London NR
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33669619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug screening by uniform patient derived colorectal cancer hydro-organoids.
    Jung YH; Choi DH; Park K; Lee SB; Kim J; Kim H; Jeong HW; Yang JH; Kim JA; Chung S; Min BS
    Biomaterials; 2021 Sep; 276():121004. PubMed ID: 34273688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.